Microbix Biosystems (MBXBF) Stock Overview

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

MBXBF Stock Information

Symbol

MBXBF

Address

265 Watline AvenueMississauga, ON L4Z 1P3Canada

Founded

Trading hours

Website

https://www.microbix.com

Country

🇨🇦 Canada

Phone Number

905 361 8910

Microbix Biosystems (MBXBF) Price Chart

Microbix Biosystems Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.28099999	N/A
Market Cap	$38.37M	N/A
Shares Outstanding	136.55M	0.87%
Employees	0	N/A
Shareholder Equity	24.62M	-1.26%

Valuation	2023	Change
P/S Ratio	3.35	N/A
P/B Ratio	1.56	N/A

Growth	2023	Change
Return on Equity	-0.0011	N/A

Earnings	2023	Change
Revenue	$11.46M	N/A
Earnings	-$27.39K	N/A
Gross Margin	0.453	N/A
Operating Margin	-0.1657	N/A
Net income margin	-0.0024	N/A

Financial Strength	2023	Change
Total Assets	$24.73M	N/A
Total Debt	$4.61M	N/A
Cash on Hand	$8.05M	N/A
Debt to Equity	0.3107	36.10%
Cash to Debt	$1.75	-24.59%
Current Ratio	$5.13	-39.36%